Skip to content
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Sign in!
Subscribe
Clinical Topics
View All
Addiction
ADHD
Anxiety
Bipolar Disorder
Depression
Emerging Approaches in Schizophrenia
Movement Disorders
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia/Schizoaffective Disorders
Sleep
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
View All
Majid Kerolous, PharmD, MPH
a:1:{i:0;s:31:"AbbVie, North Chicago, Illinois";}
JCP
Original Research
Adjunctive Cariprazine for Anxiety Symptoms in MDD
April 30, 2025
Cariprazine added to antidepressant therapy reduced anxiety symptoms in patients with and without anxiety at baseline.
Maurizio Fava
,
Prakash S. Masand
,
Vladimir Maletic
, et al
JCP
Original Research
Adjunctive Cariprazine for MDD With Inadequate Response to Antidepressants
August 16, 2023
This study assessed the efficacy of adjunctive use of cariprazine, an atypical antipsychotic, in MDD patients with inadequate response to antidepressants.
Maurizio Fava
,
Gary S. Sachs
,
Paul P. Yeung
, et al
